Cargando…

Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor

Multidrug resistance (MDR) is the main cause of clinical treatment failure and poor prognosis in cancer. Targeting P-glycoprotein (P-gp) has been regarded as an effective strategy to overcome MDR. In this work, we reported our preclinical studies of the triazolo[1,5-a]pyrimidine-based compound WS-71...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Sai-Qi, Teng, Qiu-Xu, Wang, Shuai, Lei, Zi-Ning, Hu, Hui-Hui, Lv, Hui-Fang, Chen, Bei-Bei, Wang, Jian-Zheng, Shi, Xiao-Jing, Xu, Wei-Feng, Liu, Hong-Min, Chen, Xiao-Bing, Chen, Zhe-Sheng, Yu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366537/ https://www.ncbi.nlm.nih.gov/pubmed/35967279 http://dx.doi.org/10.1016/j.apsb.2022.03.023

Ejemplares similares

Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
por: Elmeliegy, Mohamed, et al.
Publicado: (2020)

P glycoprotein (P-gp) and drug resistance--time for reappraisal?
por: Kaye, S. B.
Publicado: (1993)

Rice (Oryza sativa L.) cytochrome P450 protein 716A subfamily CYP716A16 regulates disease resistance
por: Wang, Aijun, et al.
Publicado: (2022)

Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
por: Dewanjee, Saikat, et al.
Publicado: (2017)

6-Isopropyl-3-phenyl-5-(p-tolyloxy)-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one: whole-molecule disorder
por: Zeng, Xiao-Hua, et al.
Publicado: (2009)

Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms
por: Wang, Hui-Lin, et al.
Publicado: (2017)

The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar
por: Taylor, J C, et al.
Publicado: (1999)

Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors
por: Liu, Zhenzhen, et al.
Publicado: (2020)

3-Benzyl-6-butyl-5-propyl-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
por: Zeng, Xiao-Hua, et al.
Publicado: (2010)

Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure–activity profile
por: Cacciari, Barbara, et al.
Publicado: (2006)

6-Isopropyl-5-methoxy-3-phenyl-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
por: Zeng, Xiao-Hua, et al.
Publicado: (2010)

4,6-Dimethyl-2-p-tolylpyrimidine
por: Xu, Chen, et al.
Publicado: (2009)

5-(4-Chlorophenoxy)-6-isopropyl-3-phenyl-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
por: Zeng, Xiao-Hua, et al.
Publicado: (2009)

The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses
por: Xu, Na, et al.
Publicado: (2020)

6-Butyl-5-(4-methylphenoxy)-3-phenyl-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
por: Wang, Hong-Mei, et al.
Publicado: (2010)

Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors
por: Salmaso, Veronica, et al.
Publicado: (2023)

Blue Organic Light-emitting Supramolecular Microfibers: The Self-assembly of a 1,2,4-Triazolo[1,5-a]pyrimidine Derivative
por: Liu, Zu-Ming, et al.
Publicado: (2008)

Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity
por: Merelli, Amalia, et al.
Publicado: (2019)

Glycan shield of the ebolavirus envelope glycoprotein GP
por: Peng, Weiwei, et al.
Publicado: (2022)

P-gp expression inhibition mediates placental glucocorticoid barrier opening and fetal weight loss
por: Ge, Caiyun, et al.
Publicado: (2021)

6-Butyl-5-(4-methoxyphenoxy)-3-phenyl-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
por: Zeng, Xiao-Hua, et al.
Publicado: (2009)

Functional Characterization of CYP716 Family P450 Enzymes in Triterpenoid Biosynthesis in Tomato
por: Yasumoto, Shuhei, et al.
Publicado: (2017)

Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine
por: Ma, Liping, et al.
Publicado: (2016)

Correction to: P-gp expression inhibition mediates placental glucocorticoid barrier opening and fetal weight loss
por: Ge, Caiyun, et al.
Publicado: (2022)

Syntheses of Diheterocyclic Compounds Based on 2-Thioacetohydrazide-5,7-dimethyl-1,2,4-triazolo[1,5-a]-pyrimidine
por: Liu, Zu-Ming, et al.
Publicado: (2008)

Fabrication of WS(2)/GaN p-n Junction by Wafer-Scale WS(2) Thin Film Transfer
por: Yu, Yang, et al.
Publicado: (2016)

Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies
por: Liu, Jiawang, et al.
Publicado: (2021)

De Novo Balanced Translocation t (7;16) (p22.1; p11.2) Associated with Autistic Disorder
por: Bayou, Nadia, et al.
Publicado: (2008)

Discovery of Triazolo-pyridazine/-pyrimidine Derivatives Bearing Aromatic (Heterocycle)-Coupled Azole Units as Class II c-Met Inhibitors
por: Zhang, Qian, et al.
Publicado: (2020)

P716: GENE EXPRESSION ANALYSIS REVEALS UNIQUE CHARACTERISTICS OF BONE MARROW MESENCHYMAL STROMAL CELLS IN MYELODYSPLASTIC SYNDROME WITH RING SIDEROBLASTS
por: Chen, Wanshu, et al.
Publicado: (2023)

Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells
por: Chen, Yinghui, et al.
Publicado: (2012)

Reversion of P-Glycoprotein-Mediated Multidrug Resistance in Human Leukemic Cell Line by Diallyl Trisulfide
por: Xia, Qing, et al.
Publicado: (2012)

Probing the Allosteric Modulation of P-Glycoprotein: A Medicinal Chemistry Approach Toward the Identification of Noncompetitive P-Gp Inhibitors
por: Bonito, Cátia A., et al.
Publicado: (2023)

Chemical biology fluorescent tools for in vitro investigation of the multidrug resistant P-glycoprotein (P-gp) expression in tumor cells
por: Daumar, Pierre, et al.
Publicado: (2023)

Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity
por: Baburajeev, C. P., et al.
Publicado: (2017)

3-Benzyl-6-isopropyl-5-phenoxy-3H-1,2,3-triazolo[4,5-d]pyrimidin-7(6H)-one
por: Deng, Shou-Heng, et al.
Publicado: (2009)

IBD-mediated oxidative cyclization of pyrimidinylhydrazones and concurrent Dimroth rearrangement: Synthesis of [1,2,4]triazolo[1,5-c]pyrimidine derivatives
por: Tang, Caifei, et al.
Publicado: (2013)

6-Benzyl-3-[(6-chloropyridin-3-yl)methyl]-6,7-dihydro-3H-1,2,3-triazolo[4,5-d]pyrimidin-7-imine
por: Pan, Dong-Feng, et al.
Publicado: (2011)

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor
por: Fallacara, Anna Lucia, et al.
Publicado: (2019)

Structure activity relationships and the binding mode of quinolinone-pyrimidine hybrids as reversal agents of multidrug resistance mediated by P-gp
por: Laiolo, Jerónimo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8sf4jom6586lopccnjtjv2o8j